Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
1,25-Dihydroxyvitamin D3 acts directly on the T lymphocyte vitamin D receptor to inhibit experimental autoimmune encephalomyelitis.
JC-virus seroconversion in multiple sclerosis patients receiving natalizumab.
Toso controls encephalitogenic immune responses by dendritic cells and regulatory T cells.
Microbial colonization influences early B-lineage development in the gut lamina propria.
MARGA: Multispectral Adaptive Region Growing Algorithm for brain extraction on axial MRI.
2012 Annual Meeting: Primary Immune Deficiency Disease North American Conference
Organic solvents as risk factor for autoimmune diseases: a systematic review and meta-analysis.
Human iPSC-derived oligodendrocyte progenitor cells can myelinate and rescue a mouse model of congenital hypomyelination.
Progressive multiple sclerosis: The treatment gap.
An Adult Case of Anti-Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-associated Multiphasic Acute Disseminated Encephalomyelitis at 33-year Intervals.
Current and future drugs for treatment of MS-associated bladder dysfunction.
Incidence of multiple sclerosis in Northern Lisbon, Portugal: 1998¿2007.
Interferon regulatory factor 1 regulation of oligodendrocyte injury and inflammatory demyelination.
Mesenchymal stem cells protect CNS neurons against glutamate excitotoxicity by inhibiting glutamate receptor expression and function.
A phase IIa randomized clinical study testing GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis associated endogenous retrovirus in multiple sclerosis patients - A twelve month follow-up.
CD4 cell response to interval therapy with natalizumab.
Immunohistochemical detection of sphingosine-1-phosphate and sphingosine kinase-1 in human tissue samples.
Recommendations for the clinical use of motor evoked potentials in multiple sclerosis.
Stress and hypothalamic-pituitary-adrenal axis function in experimental autoimmune encephalomyelitis and multiple sclerosis - a review.
The antiepileptic drug valproic acid restores T cell homeostasis and ameliorates pathogenesis of experimental autoimmune encephalomyelitis.
The cytokines cardiotrophin-like cytokine/cytokine-like factor-1 (CLC/CLF) and ciliary neurotrophic factor (CNTF) differ in their receptor specificities.
The chemokine receptor CCR5 Δ32 allele in natalizumab-treated multiple sclerosis.
Partnering to increase access to community exercise programs for people with stroke, acquired brain injury, and multiple sclerosis.
The environment and disease: association or causation?
Sensitivity and specificity of SWI venography for detection of cerebral venous alterations in multiple sclerosis.
Pages
« first
‹ previous
…
156
157
158
159
160
161
162
163
164
…
next ›
last »